Free tools Windows power users keep installed
One-click scans. No signup required.
The stock behind the “under-the-radar AI” prediction is Synopsys, Inc. (NASDAQ: SNPS). Its potential upside rests on demand for chip-design software, application-optimized silicon IP and engineering tools as AI systems grow more complex. Those are plausible growth drivers, not evidence that SNPS will soar: adoption, execution and future returns remain uncertain.
Why Synopsys is part of the AI investment conversation
Synopsys is best known for electronic design automation (EDA): software engineers use to design, verify and test chips. The bull case is that AI’s demand for computing power, along with increasingly complex products and systems, could expand the need for these tools. The company also sells silicon IP and is broadening its portfolio toward engineering simulation and system-level analysis through its Ansys integration.
That makes Synopsys an indirect way to invest in AI infrastructure. It is not simply a bet on one chip or model: the investment thesis depends on customers continuing to spend on chip design and related engineering capabilities. Synopsys describes AI as a source of multiple growth opportunities, but that is management’s view of its addressable market, not independent proof that demand or revenue will grow as projected. Synopsys’s 2026 Investor Day release sets out that company perspective.
What the Amazon agreement does—and does not—show
On September 30, 2026, Synopsys and Amazon announced a multi-year agreement valued at more than $1 billion. Amazon is the lead customer for expanded application-optimized silicon IP, and the collaboration also covers EDA, simulation and analysis, AI-powered engineering, and cloud collaboration. The companies said they plan to work on multiphysics solutions for Amazon’s Trainium and Graviton chips. Synopsys also plans to use AWS services, including EC2 and Bedrock, in its own development work. The announcement describes the scope of the agreement.
#1 Best Overall
The headline value is not the same as $1 billion of immediate revenue. The announcement calls it a multi-year agreement and does not say the full amount will be recognized at once. It is evidence of a significant customer relationship and a concrete use case for the company’s silicon and engineering offerings—not a guarantee of the contract’s eventual financial contribution or a measure of future stock returns.
Management’s financial goals are targets, not results
At its September 30, 2026 Investor Day, Synopsys laid out objectives for FY2026–FY2030. The company identifies several measures as non-GAAP and warns that they are forward-looking. They should be read as management’s goals, not as realized performance or a promise.
| Measure | Synopsys objective or outlook |
|---|---|
| Revenue growth | Approximately 15% over FY2026–FY2030, an objective announced by Synopsys in 2026 |
| Operating margin | Approximately 50% non-GAAP operating margin in FY2030, a company objective announced in 2026 |
| Non-GAAP EPS growth | Mid-20% range over FY2026–FY2030, a company objective announced in 2026 |
| Free-cash-flow growth | Mid-20% range over FY2026–FY2030, a company objective announced in 2026 |
| FY2027 revenue | $11.1 billion to $11.2 billion guidance; approximately $11.15 billion at the midpoint |
| FY2027 free cash flow | Approximately $3.1 billion company target |
The figures and their qualifications are from Synopsys’s Investor Day release. The company says it cannot reconcile several FY2028–FY2030 non-GAAP projections to comparable GAAP measures without unreasonable effort, citing the variability and limited predictability of excluded adjustments. That limits how directly investors can compare some of the long-range targets with GAAP results.
What could keep the prediction from coming true
A decade-long stock forecast is exposed to more than the company’s ability to meet its targets. Synopsys’s own long-term case depends on new end markets and continued adoption of technologies and workflows that may not develop as smoothly as management expects. If customers delay projects, change design approaches or spend less than anticipated, demand may fall short of the thesis.
Recommended Free Tools
- Execution: The company must deliver its growth objectives while integrating a broader engineering portfolio and converting new opportunities into business.
- Adoption: Physical AI, purpose-built silicon and AI-powered engineering must gain meaningful customer use for the newer parts of the thesis to contribute as hoped.
- Valuation and returns: Even a company that grows can produce disappointing shareholder returns if expectations embedded in its share price are too high. The supplied company targets do not establish the stock’s future return or whether its current price is attractive.
- Forecast uncertainty: Synopsys’s long-range figures are forward-looking, and some are non-GAAP; they can differ from eventual reported performance.
Does the evidence support saying SNPS will soar?
No. The evidence supports a long-term growth thesis worth evaluating: Synopsys has established EDA and silicon IP businesses, is expanding into broader engineering work, and has announced a substantial multi-year collaboration with Amazon. Management has also published ambitious FY2026–FY2030 objectives. None of those facts establishes that the shares will outperform or “soar” over the next decade.
A Motley Fool article by Lee Samaha, published October 5, 2026, reported that Deutsche Bank maintained a buy rating and raised its price target from $590 to $640 after Synopsys’s Investor Day. That is an analyst’s target as reported by the article, not a company forecast or a demonstrated probability of future gains. Samaha also offered rough 2030 valuation calculations, but those are the author’s extrapolations rather than Synopsys guidance; the article’s displayed EPS figure has an apparent unit inconsistency and should not be treated as a reliable company projection. The Motley Fool article presents the prediction as an investment opinion and acknowledges adoption risk.
For a potential investor, the useful question is not whether the headline prediction is certain—it is not—but whether Synopsys’s business prospects, execution risks and valuation fit their own investment horizon and tolerance for loss. The available evidence provides a case to assess, not a basis for assuming a decade of exceptional returns.
Quick Recap
Best Value
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
The Tool Desk
Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →
